Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Statistics is an area subject to interpretation an

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 465)
Posted On: 11/26/2020 1:08:21 PM
Posted By: Assiduous
Re: docj #23912
Statistics is an area subject to interpretation and in many case only a snapshot of a moving target. I have been watching the Worldmeters https://www.worldometers.info/coronavirus/ since March/April. When the Covid numbers were small, the death rate of CLOSED cases got up to 14%. It is now (after 43+ million closed cases) down to 3%. Still a tragic number. I emphasized CLOSED because most people would cite the death rate as a percentage of deaths among all Covid cases active and resolved. There are only two outcomes to getting Covid, you either survive or you don’t. Open cases have not been resolved. So why the long prologue?

In Doc’s find https://mises.org/wire/what-covid-vaccine-hype-fails-mention there is mentioned the total participants between Moderna and Pfizer as 73,538, with only a total of 264 resolved (CLOSED) cases. We know that these cases are closed is because they have all contracted Covid. The other 73,274 cases remain unresolved (OPEN) because no data about them has been provided. These unresolved participants can only be added to the resolved database when the drug companies can definitively confirm that they have been exposed to the Covid virus with negative results. So at this point, any efficacy figures would be misleading.

While the efficacy percentage could go up (never to 100%) if all 73,274 unresolved case prove to be negative, it is more likely that the efficacy percentage will decrease. How far, time will tell. I hope the EUA board gets and analyzes the complete data. It is bad enough that people in this country are knowingly ignoring scientific proven precautions, it would be even more tragic to have people abandon those precautions after being inoculated, assuming a false sense of security.


(4)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us